NCT02688907 2018-09-20Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 MutationSamsung Medical CenterPhase 2 Terminated7 enrolled